This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Helixmith Co., Ltd. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Juwon Shim: Innovator in Pharmaceutical Treatments
Introduction
Juwon Shim is a prominent inventor based in Anyang-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments utilizing anti-c-Met antibodies. His innovative work aims to address various diseases through targeted therapies.
Latest Patents
Juwon Shim holds 1 patent for his invention titled "Methods of treatment using anti-c-met antibodies." This patent describes a pharmaceutical composition designed to prevent or treat a variety of diseases by activating c-Met in cells through the use of the anti-c-Met antibody, which functions as a c-Met agonist. The invention highlights a method for leveraging c-Met activation to combat various health conditions.
Career Highlights
Juwon Shim is currently associated with Helixmith Co., Ltd., a company known for its focus on innovative biopharmaceutical solutions. His work at Helixmith has positioned him as a key player in the development of advanced therapeutic strategies.
Collaborations
Juwon Shim collaborates with notable colleagues, including Seung Shin Yu and Jae-Gyun Jeong. Their combined expertise contributes to the advancement of research and development in the pharmaceutical sector.
Conclusion
Juwon Shim's contributions to the field of pharmaceuticals through his innovative patent on anti-c-Met antibodies exemplify the impact of targeted therapies in modern medicine. His work continues to pave the way for new treatment options for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile